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Summary 
ROP is a potentially blinding disease of preterm infants. This thesis focuses on the role of 
CO2 and fluctuating O2 levels in the development of ROP. In our clinical cohort study the aim 
was to determine whether hypercarbia or hypocarbia or the variability of CO2 in the first 2 
weeks of life in extremely preterm infants were associated with the development of ROP. In 
contrast to the previous clinical studies using intermittent arterial blood gas analysis to 
associate PCO2 with pathology, we have analysed continuous tcPC02 data of infants. The 
daily mean and SD of tcPC02 was compared between infants who had stage 1 or 2 ROP and 
stage 3 ROP. The total time spent hypocarbic and/or hypercarbic was also compared between 
these groups. Intermittent PCO2 was also measured and compared with the simultaneous 
tcPC02 data. There were no significant differences in CO2 variability or time spent 
hypocarbic and/or hypercarbic between the ROP groups on any day. 86 % of transcutaneous 
values were within 1.5 kPa of the simultaneous arterial values. Our findings proved that 
tcPC02 measurement can be a very useful management technique but in our cohort neither 
variable blood CO2 tension nor duration of hypercarbia or hypocarbia in the first two weeks of 
life was associated with the development or severity of ROP. Recently, using a unique animal 
model of 02-induced retinopathy we showed that newborn rats raised in a relatively hypoxic 
but variable O2 environment (fluctuated around 17 % mean O2) develop less severe retinal 
abnormalities than those raised in variable O2 around higher (24 %) or normal (21 %) O2 
means. In our study we used the Edinburgh-model to investigate O2 variability compared with 
the combination of O2 variability and hypercarbia on the development of ROP. Neonatal rats 
were raised for 2 weeks in a fluctuating O2 environment (around 21 % mean inspired O2) with 
or without (5 %) CO2. The small but frequent changes in O2 were able to induce peripheral 
avascularity of the retina and abnormal terminal vessels. When combined with continuous 
hypercarbia the rat pups developed larger peripheral avascular area of the retina and the 
vasculature was immature and unremodelled. Abnormal, dilated vessels were present 
throughout the retina. At the vascular/avascular interface of the retina terminal buds that 
stained with endothelial cell specific lectin represented endothelial cell proliferations. 
Continuous hypercarbia combined with O2 fluctuation around a normoxic mean resulted in 
similar changes in retinal vasculature than fluctuation around mildly hyperoxic mean. 
Hypercarbia increased the severity of fluctuating 02-induced retinopathy in newborn rats. 
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1. INTRODUCTION 
1.1. History of the disease 
Retinopathy of prematurity (ROP) was first described in 1942 in infants who were bom 8 
weeks preterm1. ROP was later associated with the introduction of high concentrations (80%) 
of supplemental oxygen, given to preterm infants without arterial monitoring, for up to 8 
weeks. A reduction in inspired oxygen concentration in subsequent decades resulted in a 
dramatically reduced incidence of the disease, but this was accompanied by a dramatic 
increase in preterm mortality and handicap from hypoxia2. 
In the 1970s and 1980s, the development of techniques to continuously monitor oxygen (both 
with intra-arterial and transcutaneous probes), together with improved ventilators with better 
control of the inspired oxygen content, enabled the arterial oxygen to be maintained within 
'safe' limits. However, the increased number of extremely immature infants (up to 16 weeks 
preterm) who were able to survive because of these and other technological advances may be 
the reason that the incidence of retinopathy of prematurity has once again begun to increase 
and become the most common acquired retinal disease in premature babies3. 
1.2. Normal retinal blood vessel development 
The retina has two blood supplies, the choroidal vessels and the inner retinal vessels. The 
choroidal vasculature develops early (20-29 weeks' gestation), lies on the outer surface of the 
retina, and is the sole supplier of nourishment to the thin, undifferentiated immature retina. 
The inner retinal vasculature takes longer to develop (16-40 weeks' gestation), lies within the 
inner surface of the retina, and nourishes the inner portions of the thick, maturing retina4. One 
stimulus for the normal formation of the inner retinal blood vessels is the thickening of the 
maturing retina that displaces the inner retina further from the choroidal vessels, presumably 
increasing the levels of hypoxia in these tissues. Another stimulus is that as photoreceptors 
mature their metabolic rate increases, and they utilise more oxygen that cannot be supplied by 
the non-vasoconstricting choroidal vasculature alone4. 
The inner retinal vasculature develops from spindle cells which are the mesenchymal 
precursors of vascular endothelial cells4'5. These cells are apparent at 14 to 15 weeks' 
gestation and migrate from the optic disc centrally and in a superficial plane toward the retinal 
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periphery, reaching the ora serrata at 29 weeks' gestation4'5. The spindle cells proliferate and 
aggregate to produce cords of endothelial cells. This de novo formation of blood vessels by 
the differentiation of endothelial precursor cells is called vasculogenesis6. 
The early, primordial vessels of the human retina are formed by vasculogenesis5. However, 
angiogenesis, the formation of vessels by budding and sprouting from existing vessels5, is 
responsible for increasing the vascular density of the early vessels and peripheral 
vascularisation in the inner retina. 
Lastly, remodelling - the process of matching the vascular tree to the tissue oxygen 
requirements, comprises two distinct processes. Some capillaries coalesce into larger vessels 
and others, particularly those in proximity to arteries undergo retraction. As a result of their 
collapse, the vascular tree becomes less exuberant, and capillary-free zones are formed along 
the flanks of arteries5. The process of remodelling and maturation of the inner retinal 
vasculature is complete at 40 weeks' gestation4,5. This development is regulated first of all by 
oxygen levels in retinal tissue and vascular endothelial growth factor (VEGF) has a key-role 
during this procedure. 
VEGF is a potent angiogenic glycoprotein that is increased, and its mRNA stabilised, by 
hypoxia7'8. VEGF induces endothelial cell proliferation, promotes cell migration and inhibits 
apoptosis7'8. In the retina it is secreted by the retinal microglial cells9. During the formation 
and maturation of the retina a "physiological hypoxia" develops because of the increase in 
retinal neuronal and metabolic activity and the rise in oxygen demands of retinal tissue10'11. 
Hypoxia induces VEGF expression9,10 and the secreted VEGF causes the formation of the 
retinal vessels by its endothelial cell-specific mitogen and chemoattractant effects7. VEGF 
therefore reduces the hypoxic stimulus for retinal vessels formation, thus balancing the 
oxygen supply and demand of the retina. 
Although VEGF plays a major role in retinal vascularization, it is likely that other molecules, 
both angiogenic and angiostatic, are involved. Numerous proangiogenic molecules have been 
proposed to play a role, including growth hormone and the insulin-like growth factors12, basic 
fibroblast growth factor13, and hepatocyte growth factor14. TGF-p15 has been proposed as an 
inhibitor of retinal neovascularization and several systemic inhibitors of angiogenesis have 
been characterized, including angiostatin16, antithrombin III17, endostatin18, thrombospondin19 
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and platelet factor-420, however the role of these molecules in the process of retinal 
vascularization is unclear. 
Perhaps the most potent natural inhibitor of angiogenesis is pigment epithelium-derived factor 
(PEDF)21. It is an endogenous protein that is secreted by retinal epithelial cells into the inner 
photoreceptor matrix of the retina22 and promotes apoptosis of cells within ocular neovascular 
lesions23. PEDF is also an essential factor for normal retinal development. Recent data 
indicate that elevated concentrations of PEDF inhibit VEGF-induced retinal endothelial cell 
growth and migration and thus retinal neovascularization24. PEDF has photoreceptor and 
neuroprotective activity as well25. It has been found to be downregulated by hypoxia; in 
contrast, hyperoxia increased the expression of PEDF23,24. Therefore, like VEGF, its 
regulation by oxygen makes it potentially important in the development of ROP. However, in 
the literature there is a debate on the role of PEDF in ROP. Recently some animal models26'27 
suggested that over-expression of PEDF, or no expression of PEDF produced no 
abnormalities in the retinal vasculature. Therefore the importance of PEDF in the 
pathogenesis of ROP is still to be fully understood. 
1.3. Oxygen and carbon dioxide 
Oxygen has proven therapeutic value in newborn infants to correct, and prevent the many 
complications of hypoxia. Oxygen decreases the incidence and severity of apnoea in 
premature infants28, dilates the pulmonary arteries and increases pulmonary blood flow28, and 
constricts the ductus arteriosus28. Although its essential role in life is well known, oxygen is 
also potentially toxic. Breathing a higher than normal oxygen concentration can cause 
pulmonary epithelial cell injury and has been implicated as a principal cause of chronic lung 
disease and bronchopulmonary dysplasia in preterm infants with respiratory distress 
syndrome . Within, and adjacent to, cells throughout the body, oxygen can react with 
prooxidants to produce reactive oxygen species that then produce inflammation and even cell 
death. We have recently demonstrated that severe vasomotor changes during hypoxia 
(ischaemia/reperfusion) may result in mesenteric endothelial dysfunction implicated in the 
development of necrotizing enterocolitis (NEC), which is the most common acquired 
gastrointestinal emergency in neonates29. Oxygen is also important in the regulation of 
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cerebral vessels. Generally, higher blood oxygen levels constrict certain blood vessels, such as 
those in the retina28. 
The physiological effect of carbon dioxide in newborn infants is also very important, 
particularly as a potent respiratory stimulator and its effect on cerebral vessels. Hypocarbia 
and hypercarbia have opposite effects on the cerebral vasculature. Hypercarbia increases 
cerebral blood flow, hypocarbia reduces it30. Retinal blood flow also increases during 
hypercarbia31. Some earlier studies showed that hypercarbia could be highly protective in 
experimental models of acute ischaemic myocardial, lung or brain injury30'32,33. However, 
clinical investigation suggests that premature infants who require mechanical ventilation for 
respiratory distress syndrome are at an increased risk for periventricular leucomalacia if 
hypocapnia occurs during respiratory management30. A series of studies also investigated 
whether hypercapnia or hypocapnia might be a risk factor for ROP. 
1.4. Pathogenesis of ROP 
Retinal neovascularisation is a pathological condition in which abnormal angiogenesis can 
lead to severe consequences such as fractional retinal detachment, vitreal bleeding or 
sometimes to blindness. ROP begins to develop between 32 and 34 weeks after conception, 
regardless of gestational age at delivery34. 
Historically, ROP has been shown to have two distinct pathophysiological phases during the 
progression of the disease34. 
There have been several theories in the past, which have sought to explain the pathogenesis of 
retinopathy of prematurity. All of these concur that oxygen is implicated either directly or 
indirectly in the initiation of ROP, but the management of premature infants and our 
understanding about ROP have changed in many ways over the last 10-15 years so most of 
these explanations are out of date. 
The first acute phase of ROP is the vasoattenuation, the occlusion and the obliteration of the 
existing retinal blood vessels. The normal vasculogenesis of the retina is disturbed by the 
relative hyperoxia of the extrauterine environment. This causes vaso-obliteration and non-
vascularisation of some areas of the anterior retina. The resulting vascular insufficiency 
ultimately produces inner retinal hypoxia, leading to the second chronic phase, the 
vasoproliferation. This vasoproliferation is a poorly controlled process of retinal 
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vascularization, characterised by the proliferation of new blood vessels which are unstable 
and leaky and arteriovenous shunt formation, occasionally leading to involution or permanent 
cicatrial changes and visual impairment10. 
In the first classic theory35,36 the retinal vessels constrict and their endothelial cells are 
damaged due to raised partial pressure of oxygen (PO2) above normal for the foetus. This 
leads to ischaemia and the production of angiogenic factors and subsequent vasoproliferation. 
Kretzer et at in their theory also postulate the production of angiogenic factors but propose 
that they are not induced by vasoconstriction but direct oxidative insult to the mesenchymal 
precursor cells (spindle cells). These cells then synthesise and secrete angiogenic factors 
generating the vasoproliferative response by the retinal vessels. After premature birth oxygen 
can diffuse easily from the non-vasoconstricting choroidal vasculature, can cause 
physiological vasoconstriction of the inner retinal vasculature, and create an abnormal 
hyperoxic environment for spindle cells. 
Other investigators21,37 suggest a theory implicating the balance of growth factors and 
inhibitors, and apoptosis. The maintenance of the retinal vascular tree depends on a 
continuous supply of survival factors, which can be downregulated by oxygen. Thus 
hyperoxia induces a shutdown of VEGF and markedly increased expression of PEDF, the 
major natural inhibitor of angiogenesis, which causes endothelial apoptosis and leads to vaso-
obliteration of newly formed retinal capillaries. The ischaemia that follows generates an 
upregulation of VEGF that induces angiogenesis and the vasoproliferative response of ROP. 
38 
Brooks et al hypothesised that oxygen-induced retinal vaso-obliteration was mediated in part 
by endothelial nitric oxide (NO)-derived oxidants such as peroxynitrite. Evidence for 
peroxynitrite mediated protein modification and cellular injury has been reported in cerebral 
ischaemia39, myocardial ischaemia-reperfusion40 and experimental models of retinal 
ischaemia41. These important in situ mediators of oxidative injury may also have a pathogenic 
role in oxygen-induced retinopathy in developing retina by protein modification and direct 
cytotoxicity. 
1.5. Risk factors 
ROP is a multifactorial disease42 with gestational age34,42,43,44 and low birth weight4,34,42 being 
the most powerful predictors of progression to disease. 
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1.5.1. Oxygen and the development ofROP 
Although in the early 40s and 50s it was postulated that high arterial oxygen levels45,46 were 
the cause, more recently data has shown that fluctuations in arterial blood oxygen tension47 
are more closely related to the development and severity of the disease. 
Johns et a/48 showed that premature infants with cyanotic congenital heart disease can 
develop ROP despite persistent hypoxia. In their study the infant population was persistently 
hypoxic, but generally they had normal arterial carbon dioxide levels and pH values. 
Previous data suggested that infants with a partial pressure of oxygen (PO2) more than or 
equal to 80 mmHg, which correlates with an arterial pulse oxygen saturation (Sp02) of 97-100 
%, in the first two weeks of life are at an increased risk for developing severe ROP49. There 
was lower prevalence of severe ROP when the maximum Sp02 was less than or equal to 92 % 
after the first two weeks of life49. 
Continuous transcutaneous monitoring of blood gases with intermittent confirmatory analysis 
of arterial gases assists clinical staff in maintaining PO2 and partial pressure of carbon dioxide 
(PCO2) within acceptable ranges. The most recent theory47 is based on the current neonatal 
intensive care treatment strategy. Clinical staff at the Neonatal Units in Edinburgh attempt to 
maintain the transcutaneous oxygen levels of babies between the conventional alarm limits of 
6 and 10 kPa (45 - 75 mmHg) to guard against hyperoxia. However, Cunningham et at1 
demonstrated that maintaining the arterial oxygen levels within these clinically accepted 'safe' 
limits did not guard against the development of ROP. The variability of PO2 within these 
limits in the first two weeks of life was a significant predictor of severe ROP47. They 
hypothesised that the frequent small changes in PO2 in the blood may cause retinopathy by 
frequent interruption of the development of the retinal vasculature and its stabilisation, which 
is controlled by relative hypoxia and hyperoxia in response to blood supply and metabolic 
demands. The extremely preterm infants tend to fluctuate their PO2 within conventional alarm 
limits because of pathological and iatrogenic causes. These are small but frequent changes in 
the arterial oxygen, which may affect VEGF induction and suppression and prevent the 
production of stable new retinal blood vessels. Whilst these findings have major implications 
for neonatal care, it has not been possible to define a concentration, or duration of oxygen, 
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which is, or is not associated with ROP. The current consensus is that hyperoxia can be 
important in ROP initiation. 
1.5.2. CO2 and the development of ROP 
There are contradictory data in the literature on whether high or low levels of carbon dioxide 
(C02) are associated with or contribute to the development of ROP. 
Clinical studies 
Shoat et at9 reported a highly significant association between episodes of hypocarbia and the 
development ROP, but no significant association to either episodes of hypercarbia or 
hyperoxia. In agreement with this was the cohort study of Brown et also that showed that the 
mean PCO2 values were consistently lower for the group of infants with scarring retinopathy 
of prematurity but there was no association with elevated PC02. In contrast Bauer et al59 
noted a correlation between hypercarbia and ROP using discriminant analysis for statistical 
evaluation. In their study the maximum PCO2 measured, and hypercarbia associated with 
simultaneous hyperoxia, were the best discriminating variables. They suggested that retinal 
vasoconstriction due to hyperoxia may be overcome by vasodilatation from hypercarbia 
which overall facilitates the delivery of highly oxygen saturated blood to the retinal tissues. 
Animal models 
Flower et al52 support this association using an animal model. Newborn puppies made 
hypercarbic had both an increased incidence and severity of ROP. In their study the most 
significant predictor of ROP was the maximum PC02 measured that occurred simultaneously 
with elevated P02. They found that the tendency of blood vessels to dilate in response to 
elevated PC02 was greater than their tendency to constrict in response to elevated P02. Yu et 
al53 in a rat model investigated the intraretinal oxygen distribution with graded systemic 
hyperoxia with or without hypercarbia. Hyperoxia resulted in a significant increase in oxygen 
level in all layers of rat retina, which was augmented by hypercarbia. Holmes et a/54 in their 
neonatal rat model found that hypercarbia alone, followed by room air recovery, could result 
in preretinal neovascularisation In their study newborn rat pups were exposed to room air 
oxygen levels (21 % 02) and 10 % C02 ("high-inspired C02 group") or to 12.5 % oxygen 
levels and 10 % C02 ("pure hypercarbia group") for 7 days and then the animals were placed 
in room air for five days. They found that neovascularisation occurred at the junction of the 
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vascular and avascular retina in 19 % of the animals in the "high-inspired CO2 group" and 14 
% in the "pure hypercarbia group". 
1.6. Aims 
Our aim was to investigate the role of oxygen fluctuation and carbon dioxide in retinopathy of 
prematurity. 
1.7. Clinical studies 
Previous clinical studies used intermittent arterial blood gas analysis to associate PCO2 with 
pathology49'50'51. Frequent blood sampling is invasive and unless performed from indwelling 
arterial lines may rapidly alter the PCO2 as the infant either cries or holds its breath55. This 
would not permit analysis of variability of blood CO2 whereas non-invasive transcutaneous 
measurement, as performed in this study does. 
A computerised cotside monitoring system at the Neonatal Unit of Simpsons Memorial 
Maternity Pavilion (Edinburgh, UK) continually stores physiological data (including P02, 
PCO2, pH) from all intensive care neonates. It is a personal computer based cotside network 
system with a central server, which accesses information each second from standard neonatal 
monitors. Up to 32 channels of physiological data can be monitored at any time. The 
technique allows the review of corresponding physiological graphs and the use of notes to 
indicate changes in therapy and patient interventions56. We analysed continuous 
transcutaneous carbon dioxide data from this computerised monitoring system calibrating this 
with intermittent arterial samples. 
Our aim was to determine whether hypercarbia or hypocarbia or the variability of CO2 in the 
first two weeks of life in extremely preterm infants were associated with the development of 
ROP. 
1.8. Animal models 
A newborn rat retina is not fully vascularised and the process takes about 14 days to complete. 
This makes a rat at birth roughly equivalent to a 24-week gestation human preterm infant and 
a useful tool for investigating retinal vascularisation. 
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Inducing retinopathy in the rat has not been totally successful. Exposure to 80% oxygen 
followed by a period in room air, results in the vasoattenuation but not the vasoproliferative 
stage of the disease57. Other studies have used large swings of 80 % to 40 % oxygen over 12 
hour periods57, going from 80 % to room air58 or from 50 % to 10 %59. These studies result in 
the acute oxygen injury, which is typically seen in preterm babies developing severe ROP, but 
not the later retinal detachment stage. Whilst they have helped to investigate how large swings 
in oxygen contribute to the development and severity of the disease, they only partially mimic 
what is experienced by an extremely preterm infant currently. 
Investigation of elevated carbon dioxide in rats has shown that both alone and in combination 
with high oxygen it increases the severity of disease54. In this study the role of combined 
carbon dioxide and variable oxygen in an animal model of ROP was investigated. A 
previously developed computer controlled oxygen delivery system has allowed a more 
representative model of newborn arterial oxygen to be developed. It enables the simulation in 
rats of transcutaneous arterialised oxygen values recorded from an infant who developed 
severe retinopathy of prematurity60. It is suitable to investigate the role of clinically relevant 
fluctuations in oxygen with or without the combination of hypercarbia on the development 
and severity of ROP. 
2. M A T E R I A L S A N D M E T H O D S 
2.1. Clinical study 
2.1.1. Patients 
This was a retrospective cohort study of infants who were admitted to the Neonatal Intensive 
Care Unit, Edinburgh, between 1996 and 1998. Inclusion criteria were 14 days of continuous 
monitored data of transcutaneous CO2, at least stage 1 ROP and less than 1001 gram birth 
weight or less than 30 weeks of gestation. 
2.1.2. Data collection 
A computerised neonatal cot monitoring system in routine clinical use recorded physiological 
data including transcutaneous carbon dioxide pressure (tcPC02) from Hewlett Packard 
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combined oxygen and carbon dioxide probes and 78344A neonatal monitors. The data were 
recorded every second and later stored as a one-minute average of 60 one second data points. 
After removal of obvious artefact due to probe calibration56 the mean and standard deviation 
were calculated for each day of the first 14 days of life. For each period it was also noted the 
number of minutes that the tcPC02 was under 3 kPa, was over 10 kPa and was over 12 kPa. 
All values were further aggregated over a week or 2-week period to produce a single mean for 
each statistic for each baby. Arterial carbon dioxide tension (PCO2) was also measured 
intermittently by umbilical or peripheral arterial catheter sample and compared to the 
simultaneous transcutaneous CO2 data. 
2.1.3. Classification of ROP 
Retinopathy of prematurity was diagnosed using binocular indirect ophthalmoscopy with a 
speculum and scleral indentation. Careful 360° examination of the peripheral retina up to the 
ora serrata was performed in every instance, by one of two experienced paediatric 
ophthalmologists. The first examination occurred at 4-6 weeks post delivery and was repeated 
weekly until the retina was fully vascularised. ROP was determined using the international 
classification for ROP61. 
2.1.4. Clinical stages 
Active ROP. Clinically, ROP is classified by the International Classification of Retinopathy of 
Prematurity61. The severity of active ROP is classified by stage, but its location within the 
retina is also important. 
Stage 1 (demarcation line). The development of a thin tortuous line, which runs roughly 
parallel with the ora serrata, is more prominent in the temporal periphery, lying within the 
plane of the retina at the junction of the vascularized and the peripheral avascular retina. The 
demarcation is the accumulation of the mesenchymal precursors of the retinal vessels. 
Stage 2 (ridge). The demarcation line develops into a ridge of tissue, which extends out of the 
plane of the retina. The ridge represents a mesenchymal shunt, which joins veins with arteries. 
Stage 3 (ridge with extraretinal fibrovascular proliferation). It is the development of 
fibrovascular proliferation along the surface of the retina into the vitreous. These findings are 
often associated with dilatation and tortuosity of the retinal blood vessels and retinal, vitreous 
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haemorrhage. The highest incidence of this stage is around the postconceptual age of 35 
weeks. 
Stage 4 (subtotal retinal detachment). The progression of fibrovascular proliferation gives rise 
to a tractional retinal detachment, which starts in the extreme periphery and then spreads 
centrally. 
Stage 5 (total retinal detachment). Typically develops when the infant is about 10 weeks old. 
'Plus' disease. It is characterized by dilatation of veins and tortuosity of the arterioles in the 
posterior pole (fundus). When these changes are present, a 'plus' sign is added to the stage 
number. 
Regressed ROP. In about 80% of infants, the ROP will regress spontaneously, leaving few if 
any residua. Complete regression is the rule for all stage 1 and 2. 
Severe ROP. Some babies with stage 3 also undergo resolution, but at this stage the likelihood 
of significant sequel is very high and some babies become blind, hence the use of the term 
severe to describe stage 3 and above. Although retinal detachment and blindness is rare, its 
development frequently preceded by progression of 'plus' disease, development of fresh 
vitreous haze, increasing preretinal and vitreous haemorrhage, gross vascular engorgement of 
the iris and failure of the pupil to dilate. 
2.1.5. Statistical analysis 
Data from the infants who were in ROP 1,2 group was compared with those who were in 
ROP3 group by repeated measures analysis of variance (SPSS). 
For each baby on each day there was a mean value of tcPC02 (with artefacts excluded) and a 
standard deviation (SD). The SDs were then averaged as a measure of variability. The daily 
means and the daily standard deviations of the babies in the ROP 1,2 and ROP3 groups were 
compared on a daily basis by t test and throughout the study using a repeated measures 
ANOVA (Analysis of Variance). A Bonferroni correction (with significance defined as p< 
0.05) was used because there were a large number of comparisons for the t test. The time in 
minutes that the tcPC02 was <3 kPa, >10 kPa and >12 kPa was calculated for each infant 
during week 1 and again during week 2. The values in ROP 1,2 group were compared with 
ROP3 group using a Student t test. 
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2.2. Laboratory study 
This was a group-controlled study with masking of samples prior to assessment. Approval for 
this study was given by the UK Home Office, and all animals were cared for in accordance 
with UK Home Office legislation. 
2.2.1. Experimental methods 
Derivation of rat oxygen profile 
The transcutaneous oxygen values from an infant who developed severe retinopathy of 
prematurity was recorded using a computerised cot monitoring system60. These values were 
averaged every minute for 14 days and artefacts (from calibration or when air was trapped 
under the sensors) were removed manually. This resulted in a stream of 21326 transcutaneous 
oxygen values, representing partial pressure of arterial oxygen, one value per minute. The 
values were translated from the transcutaneous oxygen values to percentage inspired oxygen 
for the rat - as this relationship is linear57 (Figure 1.). 
Figure 1. Percentage inspired oxygen values for the rat 
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Staff in neonatal unit attempt to maintain the PO2 in preterm infants - between 6 and 10 kPa 
(45 - 75 mmHg) with a mean of 8 kPa (60 mmHg). However a newborn rat breathing 21% 
oxygen has an arterial value of 12.9 kPa (96.8 mmHg) and therefore we had to translate the 
values to give an equivalent rat for the preterm arterial value. This was achieved by adding 
4.9 kPa (36.8 mmHg) to every preterm value. From this set of values we derived the inspired 
oxygen in the rat that would produce the equivalent arterial oxygen as the relationship 
between arterial and inspired oxygen in the rat is linear57. The rat pups were then raised for 14 
days in a specially built animal cage in which a computer controlled the atmosphere to mimic 
the fluctuating oxygen profile60. The system was designed and built by BioSpherix (Redfield, 
NY, USA) (Figure 2). 
Figure 2. Animal cage 
Sensors and gas inlet 
\ 
Fans Gas nixing 
The system delivers either oxygen or nitrogen to effect the required atmospheric change in 
oxygen. It is capable of producing up to a ± 50 % change in atmospheric oxygen within one 
minute and proved at testing to be sufficiently precise60 (Figure 3). 
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Figure 3. Diagrammatic overview of the system 
The median difference between required and monitored value of oxygen was 0.3 %, with an 
interquartile range (IQR) of 0.2 - 0.7 % (n= 17456). 85 % of all monitored readings were 
within 1% oxygen either side of the set point; 95 % were within ± 2 % oxygen. The computer 
system was also capable of preserving continuous carbon dioxide concentration in the animal 
cage during 14 days using C 0 2 gas cylinders simultaneously working with the minute oxygen 
variable profile (Figure 4). 
Figure 4. Carbon dioxide and oxygen profile (values represent 3 days) 
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2.2.2. Animal groups 
Newborn Sprague-Dawley rat pups were used in our animal model. Three groups of animals 
were studied, each for 14 days (Figure 5): 
• control group raised in room air (C) 
• the variable oxygen group (V) 
• the variable oxygen group combined with continuous, simultaneous 5% carbon 
dioxide(V/C02) 
Figure 5. Groups of rats 
Room air Variable 0 2 Variable O2 with 
controls 
4 5 * 
group 
4 5 > 
continuous 5% CO2 group 
n = 30 n = 30 n = 28 
At DAYS 14 rat pups were: 
1. weighed 
2. anaesthetised 
3. perfused cardially 
4. euthanised 
5. retinas analysed 
23 
Pregnant animals were acclimatised to isolators at least 24 hours prior to delivery. A 
minimum of 12 pups was required per litter, which all rat mothers produced in these 
experiments. Experiments were begun within 4 hours of the delivery of the final pup in each 
litter. Bedding was changed every 7 days at which point the profile was paused and restarted a 
few minutes later. No other interruption to the profile was required. 
At 14 days the rat pups were weighed and anaesthetised by intraperitoneal injection of 
ketamine (2.5 mg/kg) and xylazine (1 mg/kg). Paraformaldehyde (PFA) was then directly 
perfused (0.4 mis 0.5 %) into the left ventricle, prior to euthanasia by intracardiac injection of 
pentobarbitone (80 mg/kg). Both eyes were enucleated. Left eyes were used for retinal 
flatmounts and lectin staining. Right eyes were frozen and later cryosectioned for VEGF in-
situ hybridisation. 
2.2.3. The preparation of tissues 
Retinal wholemounts 
The retinas were dissected using a modification of the method of Chan-Ling62. Enucleated 
eyeballs were fixed whole in 2 % PFA for 2 hours before being washed in 1 M phosphate-
buffered saline (PBS) pH 7.4. Under a dissecting microscope an incision was made at the 
limbus between the cornea and sclera. Scissors were then used to cut round the junction 
between the cornea and sclera until the cornea could be removed. The lens was gently 
removed, taking care not to remove the retina. The eyecup was transferred to 1 M PBS for 
further dissection. The retina was gently eased from the sclera using fine forceps, taking care 
to leave the ora serrata intact as it defines the edge of the retina. The retina was then placed 
onto a TESPA (3'aminopropyltriethoxysilane) coated slide and flattened by making four 
incisions perpendicular to its outer edge. At this stage as much vitreous as possible was 
removed using cellulose sponges and scissors. 
Lectin stain 
Endothelial cells were visualized by incubation of Griffonia simplicifolia (Bandeiraea) 
isolectin B4 as follows. The flattened wholemounted retinas were permeabilised in 70 % v/v 
ethanol (kept at -20 °C) for 20 minutes, and then in 1 M PBS/1 % Triton X-100 for 30 
minutes. The retinas were then incubated with biotinylated G. simplicifolia (Bandeiraea) 
isolectin B4 (ICN Pharmaceuticals, UK) at 5 pg/ml in 1M PBS overnight at 4 °C. They were 
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rinsed in 1 M PBS/1 % Triton X-100 for 10 minutes, then in 1 M PBS for 10 minutes twice. 
Streptavidin-conjugated flourescein isothiocyanate (FITC) (Sigma Chemical, USA) at 25 
pg/ml in 1 M PBS was added for 4 hours at room temperature and the slides were rinsed twice 
in 1 M PBS for 10 minutes each. The retinas were mounted in PBS:glycerol (2:1) and the 
coverslip was sealed with nail varnish. 
Immunohistochemistry 
The whole enucleated eyeball was pierced by a needle and fixed in 4 % (PFA) for 2 hours. It 
was washed twice in 1 M PBS (pH 7.4) before being embedded in agarose (1.5 % in 1 M PBS 
pH 7.4 supplemented with 5 % sucrose). The solid agarose blocks were trimmed and left in 30 
% sucrose overnight at 4 °C or until the agarose block sank. The blocks were then frozen 
slowly and stored at -70 °C until sectioning. Serial cryosections 10 pm thick were made from 
whole frozen eyes and incubated for 1 hour using biotinylated G. simplicifolia (Bandeiraea) 
isolectin B4 (ICN Pharmaceuticals, UK) at 12.5 pg/ml in Tris-buffered saline (TBS). After 
successive washes in TBS the slides were then incubated with peroxidase-labelled 
streptavidin (Dako, UK) at 8.75 pg/ml for 1 hour. After washing, diaminobenzidine (DAB) 
was applied for 5 minutes, the slides were rinsed in tap water and counterstained in 
haematoxylin before being mounted in Depex (BDH Chemicals, UK) and viewed under a 
light microscope. Slides were analysed for pre-retinal vessels that grow out from the surface 
of the retina. 
Analysis 
The stained, flatmounted retinas were viewed using argon/krypton laser confocal microscope 
(Leica, Germany), which allowed low- and high-powered images to be taken and digitally 
stored for later analysis of peripheral avascular areas, central capillary density and 
neovascularisation of the retina. 
2.2.4. Capillary density 
Capillary bed sample areas were chosen in the central retina with no major vessels present in 
the fields analysed. As each retina has four quadrants, to allow flattening onto the slide, one 
area from the centre of each quadrant was imaged, making four areas in total. Images were 
taken at x20 magnification and stored later analysis. All stored files were assigned a random 
number to mask the observers and counts of the number of branches were made. One observer 
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counted all files and a second observer counted a sub-set to compare results. There was a 
statistically significant correlation (p<0.05) between the two observers using a Pearson 
correlation, and no evidence of bias assessed using a Bland-Altmann plot. 
2.2.5. Avascular areas 
Digitised images of the total retinal area and peripheral avascular area were measured using 
Scion Image Software (Scion Corporation, MD, USA) and the avascular area was expressed 
as a percentage of the total retinal area. 
2.2.6. Neovascularisation of the retina 
Digitised images of the total retinal area were analysed and the presence or absence of 
JC * 
neovascularisation was recorded by two, masked, independent ophthalmologist . 
The different groups were compared using multilevel analysis. 
2.2.7. In-situ hybridisation 
10 pm sections were cut from frozen eyes (as above) using a Leica CM 1300 cryostat and 
transferred to TESPA coated slides. Slides were air-dried for at least 30 minutes before 
storage at -20 °C until required. 
VEGF probes 
DNA from exons 1-4 (392 b.p.) were cloned into a pBluescript IIKS (Stratagene, USA) at the 
Sac II site (gift from Dr Steve Charnock-Jones, University of Cambridge, UK). The plasmid 
was digested with Sacl restriction endonuclease and end filled using T4 DNA polymerase. A 
DIG labelled sense probe was generated using T3 RNA polymerase (Roche Molecular 
Biochemicals). The antisense probe was generated by digesting the plasmid with BamHl 
restriction endonuclease. After purification using Elutip columns (Schleicher and Schuell, 
USA), the DNA was transcribed in vitro with T7 polymerase in the presence of DIG-UTP 
(Roche Molecular Biochemicals). The size of both probes was confirmed using Agarose gel 
electrophoresis. 
Method for VEGF identification 
Frozen sections were allowed to defrost at room temperature for at least 1 hour, and 
hybridised with probe overnight at 65 °C. Slides were washed at 65 °C in SSC buffer (3 M 
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sodium chloride, 0.3 M sodium citrate, pH 7) with 50 % formamide, 0.1 % Triton X-100 and 
then at room temperature in TBST (0.14 M NaCl, 2.7 mM KC1, 0.025 M Tris HC1 pH 7.5, 1 
% Triton X-100). Slides were then blocked in 10 % heat-inactivated sheep serum (in TBST) 
for > 1 hour at room temperature. Anti-DIG AP-Fab fragment (in 10 % heat-inactivated sheep 
serum in TBST) was then added to each section and incubated overnight in a humidified 
chamber at 4 °C. Slides were washed in TBST at room temperature, then in NTMT (100 mM 
NaCl, 100 mM Tris HCI pH 9.5, 50 mM MgCl2, 0.1 % Triton X-100). Staining was 
performed in the dark with nitroblue tetrazolium (NBT + 3.5 % 5-Bromo-4-chloro-3-indolyl 
phosphate /BCIP/ in NTMT). After a few hours staining reaction was checked though colour 
development could take up to 24 hours at 4 °C. The reaction was stopped using distilled water 
and the sections fixed in 4 % PFA/0.1 % gluteraldehyde for 20 minutes. The sections were 
dehydrated through a series of alcohols then counterstained with filtered 0.1 % eosin in 95 % 
ethanol for 20-30 seconds. Rinses were made in 95 % then 100 % ethanol before transferral to 
histoclear and mounting in Vecta mount (Vector Laboratories, UK). 
VEGF concentration in retinal sections 
The presence or absence of VEGF mRNA assessed by in-situ hybridisation in retinal sections 
was qualitatively scored by two masked, independent observers. 
2.3. Statistics 
Summary statistics are presented as means (± standard deviation) or median and interquartile 
range. Correlation between groups was by Pearson correlation and correlation of between-
group differences was made by Mann-Whitney U. The capillary branching was compared 
between groups by multilevel analysis using the software package ML Win (Institute of 
Education, University of London). 
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3. RESULTS 
3.1. Clinical study 
Over the 2-year period 50 infants were diagnosed with any stage of ROP and 25 of these 
babies met the requirements of the inclusion criteria. The others failed mainly because of a 
lack of the 2 weeks of continuous monitoring data, which is the strength of the study. Infants 
enrolled on the study had a mean (range) birth weight of 691 g (530-1245 g) and gestational 
age 25.2 weeks (24-29). 10 were in the ROPl,2 group and 15 were in the ROP3 group. 
There was no statistical difference between mean tcPC02 values or in the variability of 
tcPC02 during the first 14 days of life between the two groups (Table I). 
Table 1. Mean (standard deviation) and the variability of tcPC02 (in kPa) during the first 14 
days of life in the ROPl,2 and the ROP3 group. Significance was defined as p< 0.05 however 
there were no significant differences between the groups on any day. 
Day Day Day Day Day Day 
1 2 3 4 5 6 
Day 
7 
Day 
8 
Day 
9 
Day 
10 
Day 
11 
Day 
12 
Day 
13 
Day 
14 
ROPl,2 
Mean 
tcPC02 
5.3 5.9 6.1 6.0 5.9 6.2 
(1.0) (0.7) (0.8) (1.1) (0.8) (0.9) 
6.6 
(0.9) 
6.4 
(1.0) 
6.1 
(1.1) 
6.6 
(1.3) 
6.8 
(1.5) 
6.5 
(1.9) 
6.8 
(1.4) 
7.1 
(1.4) 
ROP3 
Mean 
tcPC02 
5.7 6.1 6.2 6.4 6.2 6.2 
(1.0) (0.9) (0.8) (0.9) (1.1) (1.3) 
6.7 
(1.4) 
6.8 
(1.1) 
6.8 
(1.1) 
6.9 
(1.2) 
7.1 
(1.4) 
6.7 
(1.4) 
6.6 
(1.6) 
7.1 
(1.6) 
ROP 1,2 
Variability 
of tcPC02 
1.0 1.0 0.9 1.0 1.0 0.9 
(0.3) (0.3) (0.4) (0.2) (0.4) (0.2) 
1.0 
(0.3) 
1.0 
(0.4) 
1.0 
(0.2) 
1.0 
(0.4) 
0.9 
(0.4) 
0.8 
(0.1) 
0.9 
(0.2) 
1.0 
(0.5) 
ROP3 
Variability 
of tcPC02 
1.3 1.2 0.9 0.9 0.8 0.9 
(0.5) (0.5) (0.3) (0.3) (0.2) (0.2) 
1.0 
(0.5) 
1.0 
(0.4) 
0.9 
(0.3) 
1.0 
(0.3) 
1.0 
(0.5) 
0.9 
(0.4) 
1.0 
(0.2) 
0.9 
(0.4) 
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The length of time that the tcPC0 2 was under 3 kPa, was over 10 kPa or was over 12 kPa was 
also not significantly different between the ROPl,2 and ROP3 group in either the first or the 
second week of life (Figure 6). 
Figure 6. The median (interquartile range /IQR/) of the duration of tcPC0 2 levels <3 kPa, 
>10 kPa and >12 kPa during the first and second week of life in the ROPl,2 and ROP3 group. 
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Figure 7 is a Bland-Altmann plot of the intermittently measured PC0 2 versus the 
simultaneous tcPC0 2 data and the differences were not significant. 85.8 % of transcutaneous 
values were within 1.5 kPa of the simultaneous arterial value, and a difference of <1.5 kPa 
between tcPC0 2 and PC0 2 was accepted in this study as a satisfactory agreement. 
Figure 7. The comparison of transcutaneous and simultaneous arterial PC0 2 . 
DIFFERENCE = difference between PC0 2 and tcPC0 2 (in kPa) at the time of each arterial 
blood gas measurement. 
AVERAGE = mean of PC0 2 and tcPC0 2 (in kPa) at the time of each arterial blood 
gas measurement. 
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3.2. Laboratory study 
3.2.1. Assessment of vascular injury 
Three methods of assessing changes in the vasculature are described, two quantitative 
measures of the vasculature from an assessment of lectin stained retinal flatmounts (radial 
extent of retinal vasculature and capillary concentration) and a semi-quantitative assessment 
of retinal sections by in-situ hybridisation for VEGF. All samples were randomised once 
processed for analysis and counts. 
3.2.2. Retinal wholemounts 
Peripheral avascularity 
30 animals were assessed in the minute variable oxygen and control groups and 25 in the 
minute variable oxygen combined with continuous CO2 group at 14 days postnatal age. 
Results are given in table 2. 
Table 2. Analysis of lectin stained whole flatmounted retinas for each experimental group. 
Comparison made using multilevel analysis. 
ap< 0.05, bp< 0.01, cp< 0.001 compared to Control 
dp< 0.001 V/CO2 versus V. *n=16 
n 
Number of 
branches/mm2 
(median) 
Peripheral 
avascularity 
(% total retina 
area) 
% Retinas with 
abnormal 
terminal vessels 
Mean 
weights (g) 
(95% CI) 
Control(C) 30 277 
(253 - 311) 
0 
(0 -0) 
0 29.2 
(28.8-31.9) 
Variable 
02(V) 
30 a261 
(215 -290) 
c1.7 
(0 - 7.9) 
21 c23.7 
(23.5 -23.9) 
Variable O2 
&5%C02 
(V/CO2) 
28 c'd346 
(339 - 354) 
c4.2 
(3.1 -4.9) 
44* b25.4 
(23.2 -25.7) 
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Control animals had fully vascularised retinas, however both the experimental groups had a 
significantly larger median peripheral avascular area. The variable oxygen group had median 
1.7%, the C02-variable oxygen group had median 4.2 % peripheral avascularity (Table 2). 
Between the two variable groups was a subtle but not statistically significant difference in the 
degree of avascularity (Graph I). 
Graph 1. The degree of peripheral avascularity of retina 
Control 
""multilevel analysis 
Variable 0 2 Variable 0 2 + C02 
Animal groups 
Edge of retina taken from a representative image in each experimental group showing the 
degree of avascularity. 
Figure 8, 9 and 10 demonstrates lectin stained retinal flat mounts that shows typical pictures 
of the relative degree of avascularity in the two variable groups and the fully vascularised 
retina in room air controls. 
Figure 8. Control 
fully vascularized edge of retina 
(magnification, 1 Ox) 
Figure 9. Variable O2 
peripheral avascular area 
(magnification,! Ox) 
Figure 10. Variable02 + C 0 2 
larger peripheral avascular area, 
abnormal dilated vessels on 
vascular/avascular interface 
(white arrows) 
(magnification, lOx) 
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Capillary density 
2 • Graph 2 demonstrates the number (Median and IQR) of capillary branches per mm of retina 
in the three experimental group. There was slightly, but significantly lower capillary density 
in the variable oxygen group compared to control (p<0.05) using multilevel analysis. The 
comparison between the variable oxygen group and the C02-variable oxygen group showed a 
highly significant difference (p<0.001) in the number of capillary branches. In the C02-
variable oxygen group were more capillary branches compare with the two other groups and 
the vasculature was qualitatively different as well. 
Graph 2. Number of capillary branches of retina (Median, IQR) 
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During maturation of retinal arteries retraction of capillary connections contributes to the 
formation of a peri-arterial capillary-free zone. 
Figure 11, 12 and 13 shows images captured from one typical retinal capillary bed from each 
experimental group. The vasculature of the retina in the control group showed a normal 
remodelled vasculature. The capillary bed in the CC>2-variable oxygen group was qualitatively 
different to that of the controls and the variable oxygen group. The appearance suggesting an 
immature, unremodelled vasculature with dilated capillaries, with more capillary branches 
and large vessels without a peri-arterial capillary-free zone. 
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Figure 11. Control 
normal remodelled vasculature; 
absence of abnormal dilated vessels, 
capillary free zones 
(marked with asterisk) 
(magnification 20x) 
Figure 12. Variable 0 2 
similar capillary density as in control, 
with some abnormal dilated vessels 
(white arrow), 
less capillary free zone 
(magnification 2Ox) 
Figure 13. Variable O z + C 0 2 
unremodelled homogenous, 
immature vasculature; 
dilated vessels, resembling 
sinusoid-like embryonal capillaries 
(white arrows), more capillary branches, 
higher capillary density, 
absence of capillary-free zones 
(magnification 20x) 
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Abnormal vessels 
Observers noted no extra-retinal neovascularisation on the flatmounts though these are often 
difficult to distinguish in these preparations. 
Although, there was no neovascularisation seen in any group, two masked observers noted 
abnormal terminal dilatations present at the vascular/avascular interface of 21 % of retinas 
from the variable oxygen group and 44 % of the retinas (Graph 3) in C02-variable oxygen 
group. 
Graph 3. % Retinas with abnormal terminal vessels 
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Figure 14 represents the capillary bed from the C02-variable oxygen group which has the 
appearance of a 14 days old rat pup's unremodelled immature vasculature with more capillary 
branches and the presence of abnormal terminal dilated vessels on the vascular/avascular 
interface. This picture (white arrows) shows an endothelial cell sheet that is part of the 
abnormal vascular development. Figure 14 also demonstrates a typical picture of the large 
peripheral avascular zone. 
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Figure 14. Peripheral avascularity and abnormal terminal vessels in V/C0 2 group 
(magnification, 1 Ox) 
3.2.3. Immunohistochemistry 
Immunohistochemistry to stain endothelial cells was performed on serial cryosections from 
each group but no evidence of nuclei above the inner limiting membrane i.e. extraretinal 
neovascularisation was seen. 
3.2.4. Assessment of VEGF by in-situ hybridisation 
VEGF mRNA was demonstrated in retinas using in-situ hybridisation and scored semi-
quantitatively. VEGF was found in both the anterior retina and the retina as a whole, though 
staining was more intense in the anterior retina in most specimens. Supposing a change 
evoked by variable P02 , we have analysed VEGF by in-situ hybridisation in control and 
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variable oxygen group. There was an increasing strength of staining present in the variable 
oxygen group compared with room air controls (Figure 15). 
Figure 15 demonstrates a cryosection with VEGF mRNA stained in dark purple from a retina 
in variable oxygen group. Cryosections through the centre of the eye from 14-day-old rats. 
VEGF is located in the inner nuclear layer (black arrow) as previously reported37, but in 
control group had little if any VEGF presented (blue arrows - retinal surface). 
(magnification, 5 Ox) 
Variable oxygen group Control 
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4. DISCUSSION 
4.1. 	Clinical study 
Our present clinical study does not support the view that either increased variability of blood 
CO2 or a particular duration of hypercarbia or hypocarbia in the first two weeks of life is 
related to the development or severity of ROP 63 
Some studies have reported a relationship between hypercarbia and the development of 
ROP52 ' 64  In contrast others have noted a significant association between hypocarbia and 
ROP49 ' 5o  In addition there is a body of animal studies suggesting that elevated PCO2 alone, 
followed by room air recovery, contributes to the development of ROP 54  
In this study blood CO2 levels were measured by a continuous transcutaneous monitoring 
system for 14 days. After the removal of obvious artefact this resulted in nearly 20,000 
tcPCO2 data points per baby - each of which in itself was a one-minute average of 60 one-
second points. An objective analysis was then possible. It was also important to compare the 
transcutaneous CO2 data with the simultaneous but intermittently measured arterial carbon 
dioxide tension. We found that agreement between the methods was usually excellent, with 
85.8 % of transcutaneous values being within 1.5 kPa of the simultaneous arterial value - a 
comparison, which we felt, was clinically highly satisfactory. This confirms the usefulness of 
transcutaneous PCO2 measurement. 
All previous clinical studies have used intermittent measurement of blood carbon dioxide 
tension. Frequent blood sampling is invasive and additionally this would not permit analysis 
of variability of blood CO2 whereas non-invasive transcutaneous measurement does. The 
difference in the method of monitoring blood CO2 may also explain some of the differences of 
our results compared with some previous studies 49 ' 50 ' 51  Some studies were performed before 
agreement on an International Classification of ROP was reached 61 and the use of older 
classification systems in these studies makes direct comparison with our study difficult. The 
survival of the extremely immature neonate has dramatically increased during the last 20 
years and our study population may behave differently from those older studies. 
The number of infants enrolled in the study was small but the confidence intervals of the 
results suggest that the lack of difference between groups is unlikely to be related to small 
numbers creating a type II error. It would certainly be preferable to involve more babies, but 
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during the 2-year period of investigation only 25 infants met the requirements of the inclusion 
criteria. A larger multicentre study would probably be impossible because of absence of 
similar monitoring equipment in other units. 
4.2. Animal study 
The Edinburgh group has developed an animal model of ROP based on clinically relevant 
fluctuations in oxygen60'65. It demonstrated that small, frequent fluctuations in oxygen, 
mimicking those experienced by a human preterm could induce features of retinopathy in 
neonatal rats. 
Although previous groups have induced retinopathy using large fluctuations of 40 %-70 % 
oxygen59'66'67, 80 % to 40 % oxygen57, 80 % to room air58 or from 50 % to 10 %59 over 
periods of 6-48 hours, our model produced a change in oxygen each minute. 
The development of models for identifying the pathogenesis of ROP has predominantly 
concentrated on extreme oxygen injury68. Although these models are able to induce 
retinopathy with neovascularization69'70, they have not closely represented the arterial oxygen 
of the preterm infant who might in current times develop the disease, and this has been 
considered a potential weakness in understanding the precise pathogenesis of the disease in 
extremely preterm infants. Therefore, whether the oxygen injuries induced in previous animal 
models of ROP are representative of human disease, especially in terms of ROP in 21st 
century, is debatable. 
The Edinburgh animal model, based on the arterial oxygen data derived from an infant with 
ROP, is able to more closely represent the retinal oxygenation of a preterm infant developing 
ROP than has previously been possible. Subtle changes in inspired oxygen and clinically 
relevant profiles contrasts with previous animal models of ROP, which, although they may 
characterize severe neovascularization, do not reflect the present-day clinical management of 
oxygen therapy. 
The known effects of C02 tension on small vessel calibre make it inappropriate to discard 
C02 as an important factor from our clinical study alone. It may be that specific interaction of 
CO2 with the oxygen is more important51'52'53. 
Our model is capable of preserving continuous carbon dioxide simultaneously with the minute 
variable oxygen concentration in a special animal cage. We used this model to investigate the 
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oxygen variability compared with the combination of oxygen variability and hypercarbia on 
the development and severity of ROP71. In the oxygen variable group the neonatal rats were 
raised in a fluctuating oxygen environment, where 50 % of the time was spent above and 
below 21 % (mean 21.3 %) inspired oxygen. There was slightly lower capillary density in the 
variable oxygen group compare to room air control. Their peripheral retina was avascular, 
suggesting that the retinal vascular development had been retarded. The small but frequent 
changes in oxygen were able to significantly induce peripheral avascularity of the retina when 
compared with room-air controls. Abnormal terminal vessels were present at the 
vascular/avascular interface of 21 % of retinas from the variable oxygen group. 
In the C02-variable oxygen group there also developed a peripheral avascularity of the retina 
and it was slightly larger than in the other experimental group. The central capillary density in 
this group was much higher than in the other two groups and showed smaller capillary free 
zones around larger, dilated vessels. The vasculature was immature and unremodelled. 
Although, there was no neovascularisation seen in any group, the C02-variable oxygen group 
had abnormal, dilated, terminal buds present at the vascular/avascular interface of 44 % of the 
retinas, which may have resulted by the absence of apoptosis. They were stained with 
endothelial cell specific lectin and represent endothelial cell proliferations that could be 
precursors to pathologic neovascularisation. 
Apoptosis is the genetic control of cell death and viability and preserves tissue and organ 
homeostasis by eliminating senescent, damaged, or abnormal cells72. This process involves 
different gene families of inhibitors and stimulators of cell death. The endothelium is one of 
the most critical sites for the control of apoptosis in vascular remodelling. Endothelial cell-
specific mitogens, including VEGF, transduce survival signals critically maintaining 
endothelial cell viability. Inhibition of apoptosis may also be required during retinal 
endothelial cell proliferations and new blood vessels formation6. 
VEGF has been implicated in several studies in vascular development and in proliferative 
retinopathies. In part the goal of our study was to examine the localisation and qualitative 
analysis of VEGF. The presence or absence of VEGF mRNA was assessed by in-situ 
hybridisation in retinal sections. 
VEGF mRNA was present in the inner nuclear layer of the retina in variable oxygen group, 
whereas room air controls had little if any VEGF present. 
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In our study the differences in body weight between controls and experimental groups are 
similar to those in other investigators' model of oxygen-induced retinopathy54,57. In all our 
groups there was no difference between litter sizes nor in the time the pups spent with their 
dams. We do not rule out the possibility that mothers raised in the variable oxygen with or 
without continuous C02 environments were affected and may have passed this on to their 
pups indirectly, however, we did not directly measure this. 
Recently, we demonstrated that the oxygen-induced retinopathy could be influenced by small 
shifts in the mean inspired oxygen concentration. Rat pups raised in a relatively hypoxic but 
variable oxygen environment develop less severe retinal vascular abnormalities than those 
raised in variable oxygen around higher oxygen means71. Those results would suggest that 
variability around mildly hypoxic mean enables normal growth of the retina and that nursing 
infants in slightly lower oxygen may reduce the incidence and severity of ROP. In contrast, 
fluctuation around a mildly hyperoxic mean resulted in a delay of vascularization and an 
immature retinal vasculature71. Continuous hypercarbia combined with oxygen fluctuation 
around a normoxic mean resulted in very similar, abnormal changes in retinal vascularization. 
Hypercarbia increased the severity of fluctuating oxygen-induced retinopathy in newborn rats. 
4.3. Conclusions 
In our clinical study we confirmed the usefulness of transcutaneous PCO2 measurement and 
demonstrated that the variability of tcPC02 in the first 14 days of life is not associated with 
the development or severity of ROP, whereas fluctuation of tcP02 has been shown to be 
significant47,63. However, our laboratory findings in animal study showed that the pathological 
effects of oxygen in the development of ROP might be augmented by hypercarbia. The exact 
pathomechanism is not yet known. It is possible that the elevated blood PC02 may influence 
the normal autoregulation of retinal and choroidal vessels, and that the vasodilatation due to 
hypercarbia perhaps facilitates the delivery of high oxygen saturated blood to the 
retinal/choroidal tissues enlarging the toxic effect of oxygen. 
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